Author details

Full Name

Qing Kay Li

Affiliation

ORCID

Career Start Year

1997

Papers

148

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37939140	Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.	Clin Cancer Res	2024
37425893	Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer.		2023
37835574	Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong.	Cancers (Basel)	2023
36765916	Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection.	Cancers (Basel)	2023
36994101	Shared features of metaplasia and the development of adenocarcinoma in the stomach and esophagus.		2023
35332262	Molecular landscape of pediatric type IDH wildtype, H3 wildtype hemispheric glioblastomas.	Lab Invest	2022
35815721	Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas.	Brain Pathol	2022
35688557	Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy.	Journal for ImmunoTherapy of Cancer	2022
35558510	Combinations of Single-Gene Biomarkers Can Precisely Stratify 1,028 Adult Gliomas for Prognostication.	Front Oncol	2022
35798744	Characterization of core fucosylation via sequential enzymatic treatments of intact glycopeptides and mass spectrometry analysis.	Nature Communications	2022
36266629	Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma.	Clin Proteomics	2022
35411226	Improving the detection of aggressive prostate cancer using immunohistochemical staining of protein marker panels.	Am J Cancer Res	2022
35350332	Comparing Urinary Glycoproteins among Three Urogenital Cancers and Identifying Prostate Cancer-Specific Glycoproteins.	ACS Omega	2022
33417831	Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.	Cancer Cell	2021
33484686	Tropism of Severe Acute Respiratory Syndrome Coronavirus 2 for Barrett's Esophagus May Increase Susceptibility to Developing Coronavirus Disease 2019.	Gastroenterology	2021
33692446	Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.	Mod Pathol	2021
33577785	Proteogenomic and metabolomic characterization of human glioblastoma.	Cancer Cell	2021
32719746	Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL).	Front Oncol	2020
31923397	Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.	Cell	2020
32085441	A Comprehensive Analysis of FUT8 Overexpressing Prostate Cancer Cells Reveals the Role of EGFR in Castration Resistance.	Cancers (Basel)	2020
31859488	An Integrated Workflow for Global, Glyco-, and Phospho-proteomic Analysis of Tumor Tissues.	Anal Chem	2020
33096488	Incremental prognostic value and underlying biological pathways of radiomics patterns in medulloblastoma.	EBioMedicine	2020
32766361	Submucosal Tunneling Endoscopic Resection for the Management of Heterotopic Pancreas With Cystic Degeneration.	ACG Case Reports Journal	2020
32984843	Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer.	Nat Cancer	2020
32760911	Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter study.	Neuro-Oncology Advances	2020
33287876	Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets.	J Hematol Oncol	2020
33117690	Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With Medulloblastoma.	Front Oncol	2020
31360804	Pathologic Complete Response After Chemoradiation of a Massive Primary Urethral Carcinoma.	Advances in Radiation Oncology	2019
31675502	Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.	Cell	2019
30266251	Detection of RAS and RAS-associated alterations in primary lung adenocarcinomas. A correlation between molecular findings and tumor characteristics.	Human Pathology	2019
30541742	Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.	Cancer Res	2019
30055950	Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers.	Semin Cancer Biol	2019
31516538	Transthoracic fine-needle aspiration diagnosis of solid, subsolid, and partially calcified lung nodules: A retrospective study from a single academic center.	CytoJournal	2019
30861589	Whole-exome sequencing revealed mutational profiles of giant cell glioblastomas.	Brain Pathol	2019
31157548	Expression of p16 and p53 in non-small-cell lung cancer: clinicopathological correlation and potential prognostic impact.	Biomarkers in Medicine	2019
29761369	Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals.	J Neurooncol	2018
31692939	PET and CT features differentiating infectious/inflammatory from malignant mediastinal lymphadenopathy: A correlated study with endobronchial ultrasound-guided transbronchial needle aspiration.		2018
31565700	Intranuclear Inclusions in Conventional Clear Cell Renal Cell Carcinoma (ccRCC): Diagnosis and Differential Diagnosis.		2018
30459171	Mapping the O-glycoproteome using site-specific extraction of O-linked glycopeptides (EXoO).	Molecular Systems Biology	2018
29906244	De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer.	FASEB Journal	2018
29948154	Pediatric low-grade gliomas can be molecularly stratified for risk.	Acta Neuropathol	2018
29183778	Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.	Seminars in Cancer Biology	2018
28031159	Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.	Cancer Discov	2017
28504687	The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis.	Lab Invest	2017
28814946	Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.	Clin Proteomics	2017
28814544	Direct detection of early-stage cancers using circulating tumor DNA.	Sci Transl Med	2017
28844926	An Unusual Combination of Mirror-Image Dextrocardia with Familial Medulloblastoma: Is There a Histogenetic Relationship?	World Neurosurgery	2017
28719469	INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.	Am J Surg Pathol	2017
28491011	An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.	Clin Proteomics	2017
28935176	Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.	Pathology Research and Practice	2017